Mast cell tryptase and chymase in developing and mature psoriatic lesions
- 1 June 1993
- journal article
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 285 (4) , 184-192
- https://doi.org/10.1007/bf00372007
Abstract
The number and distribution of mast cells in nonlesional and lesional skin samples from 13 psoriatic patients were analyzed enzyme- and immunohistochemically. Mast cell tryptase was stained with the sensitive substrate Z-Gly-Pro-Arg-4-methoxy-2-naphthylamide, and chymase with Suc-Val-Pro-Phe-MNA and monoclonal B7 anti-chymase antibody. In addition, healthy-looking skin from 27 psoriatic patients was tape-stripped resulting in induction of the Köbner response in 9 patients. Sequential biopsies were taken before and after (7, 14 and 21 days) tape-stripping, and both tryptase and chymase were stained enzyme-histochemically. In nonlesional psoriatic skin, 70 ± 24% (mean ± SD) of the mast cells contained chymase enzyme activity, and 78 ± 18% chymase immunoreactivity. About 10% of the chymase-immunoreactive cells lacked chymase activity. In lesional psoriatic skin, tryptase-positive cells were increased in number throughout the dermis but especially beneath the epidermis. Chymase immunoreactivity paralleled the tryptase activity, whereas chymase activity was strongly diminished both in terms of mast cell numbers and in staining intensity in the papillary dermis. The apparent inactivation of chymase may be due to the action of the chymase inhibitors, α1-antitrypsin and α1-antichymotrypsin, localized immunohistochemically in mast cells of lesional and nonlesional psoriatic skin. In the developing psoriatic lesion, mast cells displaying chymase activity were already 27–38% decreased in number in the upper dermis on day 7 after tape-stripping, along with the first clinical signs of psoriasis. Earliest alterations in tryptase-positive cells were observed on day 14 as increased mast cell contacts with the epidermis combined with only a slight increase in mast cell numbers in the upper dermis. During the development of a psoriatic lesion, TC mast cells (tryptase+, chymase+) increase in number in the upper dermis, but chymase becomes inactive at an early stage. The abundant presence of active trypase but inactive chymase in the upper dermis may have a potential role in psoriasis since both of these enzymes can process several biologically active peptides and proteins.Keywords
This publication has 39 references indexed in Scilit:
- Fibrous mastocytoma in a patient with generalized cutaneous mastocytosisJournal of Cutaneous Pathology, 1992
- Cloning and characterization of a second complementary DNA for human tryptase.Journal of Clinical Investigation, 1990
- Enzyme histochemical discrimination between tryptase and chymase in mast cells of human gut.Journal of Histochemistry & Cytochemistry, 1989
- Quantification of Cutaneous Sensory Nerves and Their Substance P Content in PsoriasisJournal of Investigative Dermatology, 1989
- Interaction of Neuropeptides with Human Mast CellsInternational Archives of Allergy and Immunology, 1989
- Human skin tryptase: purification, partial characterization and comparison with human lung tryptaseBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1988
- Formalin sensitivity and differential staining of mast cells in human dermisBritish Journal of Dermatology, 1987
- Mammalian chymotrypsin-like enzymes. Comparative reactivities of rat mast cell proteases, human and dog skin chymases, and human cathepsin G with peptide 4-nitroanilide substrates and with peptide chloromethyl ketone and sulfonyl fluoride inhibitorsBiochemistry, 1985
- Histochemical demonstration of chymotrypsin like serine esterases in mucosal mast cells in four species including man.Journal of Clinical Pathology, 1985